Blog 10/16/24
America has celebrated National Pharmacy Week during the third full week of October since 1925. Ninety-nine years later, most people still think of a pharmacist as the person in a white lab coat behind a counter. However, pharmacists have moved into roles beyond the counter. At Equitas Health, pharmacists began prescribing medications in 2020 as part of an integrated healthcare team. Behind and beyond the counter, Equitas Health pharmacists provide valuable treatment information to you and your doctors & nurses.
Before the COVID-19 pandemic made virtual healthcare – also known as telehealth – a necessity, Equitas Health had already launched its TelePrEP program. All over Ohio, TelePrEP helped increase access to PrEP, which is 99% effective at stopping HIV. With TelePrEP, people could see a pharmacist for their PrEP appointments who answered their questions, signed lab orders, provided STI counseling, and prescribed their PrEP medications.
Four years later, PrEP is now available as an injection. This means you have more options when it comes to preventing HIV. An Equitas Health pharmacist can help you decide which option is best for you. We want to thank our dedicated pharmacy professionals for everything they do all year to help the communities we serve get the most out of their PrEP treatment!
Celebrate National Pharmacy Week by learning how you can get PrEP at equitashealth.com/prep or call (833)-EQUITAS(378-4827) to make an appointment today!
Blog 1/13/25
Blog 1/7/25
In recent weeks, several drug manufacturers have implemented new restrictions on 340B contract pharmacies, risking access to vital medications for low-income and uninsured patients.
Blog 11/21/24
Blog 11/7/24
Blog 10/16/24
Blog 7/29/24
Equitas Health, Ohio’s largest LGBTQ+ and HIV-serving healthcare organization, has announced new officers on the Board of Trustees. Susan McManus (she/her), vice president of business solutions marketing at Nationwide, will serve as Board chair for a one-year term through July 2025.
Blog 1/13/25
Blog 1/7/25
In recent weeks, several drug manufacturers have implemented new restrictions on 340B contract pharmacies, risking access to vital medications for low-income and uninsured patients.